Search company, investor...

Aspect Medical Systems

aspectms.com

Founded Year

1987

Stage

IPO | IPO

Total Raised

$53.54M

Date of IPO

1/28/2000

About Aspect Medical Systems

Aspect Medical Systems is developing bispectral index brain monitoring systems for preventing anesthesia awareness and improving the effectiveness of anesthesia during surgery.

Headquarters Location

One Upland Road

Norwood, Massachusetts, 02062,

United States

617-559-7000

Missing: Aspect Medical Systems's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Aspect Medical Systems's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Latest Aspect Medical Systems News

Neuro Critical Care Market to See Huge Growth by 2028 | Companies Abbott, Teleflex Incorporated, Aspect Medical Systems, Inc., CardioDynamics International Corporation

Jan 28, 2021

| Companies Abbott, Teleflex Incorporated, Aspect Medical Systems, Inc., CardioDynamics International Corporation The Neuro Critical Care Market is an intrinsic study of the current status of this business vertical and encompasses a brief synopsis about its segmentation. The report is inclusive of a nearly accurate prediction of the market scenario over the forecast period 2018 to 2028– market size with respect to valuation as sales volume. The study lends focus to the top magnates comprising the competitive landscape of Neuro Critical Care Market, as well as the geographical areas where the industry extends its horizons, in magnanimous detail. The report describes the Neuro Critical Care Market value in detail in terms of the economic and regulatory factors that are currently shaping the market’s growth trajectory, the regional segmentation of the Neuro Critical Care Market, and an analysis of the market’s downstream and upstream value and supply chains. The report offers the market growth rate, size, and forecasts at the global level in addition as for the geographic areas: Latin America, Europe, Asia Pacific, North America, and Middle East & Africa. Also, it analyses, roadways and provides the global market size of the main players in each region. Moreover, the report provides knowledge of the leading market players within the Neuro Critical Care Market. The industry-changing factors for the market segments are explored in this report. This analysis report covers the growth factors of the worldwide market based on end-users. To remain ‘ahead’ of your competitors, request for a sample>>>  https://www.factmr.com/connectus/sample?flag=S&rep_id=2284 Regional Segments Analyzed Include: Value Chain In accordance with a competitive prospect, this Neuro Critical Care report dispenses a broad array of features essential for measuring the current Neuro Critical Care Market performance along with technological advancements, business abstract, strengths and weaknesses of market position and hurdles crossed by the leading Neuro Critical Care Market players to gain leading position. Other aspects such as customer base, sales reach, local coverage, production price trends, and production cost layout are also analyzed to bestow accurate rivalry perspective. Pivotal highlights of Neuro Critical Care Market: The Neuro Critical Care Market report includes a brief about the cost analysis, key raw material used, as well as the fluctuating price trends of the war material The suppliers of the raw material and their market concentration rate have also been enlisted The manufacturing cost structures, encompassing details about the raw material, manufacturing process analysis, as well as labor costs have been enumerated in the study Substantial details about the industry chain analysis, downstream buyers, and sourcing strategies have been elucidated A separate section has been designated for the analysis of the marketing strategy adopted, as well details about the distributors that are a part of the supply chain The report is inclusive of information regarding the channels adopted for the product marketing, marketing channel development trends, pricing and brand strategies, as well as target clientele To receive extensive list of important regions, ask for TOC here >>>  https://www.factmr.com/connectus/sample?flag=T&rep_id=2284 Reason to Buy This Neuro Critical Care Market Report are: Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Market Highlights key business priorities in order to assist companies to realign their business strategies The key findings and recommendations highlight crucial progressive industry trends in the Neuro Critical Care Market, thereby allowing players to develop effective long term strategies Develop/modify business expansion plans by using substantial growth offering developed and emerging markets Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to products, segmentation and industry verticals About Us Fact.MR is an independent, pure play market intelligence firm incorporated with an objective to deliver high quality, customized market research solutions that help our clients successfully go to the market equipped with actionable insights capable of impacting crucial business decisions. Contact Us Plot No: JLT-PH1-I3A,

Aspect Medical Systems Frequently Asked Questions (FAQ)

  • When was Aspect Medical Systems founded?

    Aspect Medical Systems was founded in 1987.

  • Where is Aspect Medical Systems's headquarters?

    Aspect Medical Systems's headquarters is located at One Upland Road, Norwood.

  • What is Aspect Medical Systems's latest funding round?

    Aspect Medical Systems's latest funding round is IPO.

  • How much did Aspect Medical Systems raise?

    Aspect Medical Systems raised a total of $53.54M.

  • Who are the investors of Aspect Medical Systems?

    Investors of Aspect Medical Systems include New Enterprise Associates, Star Ventures and QuestMark Partners.

  • Who are Aspect Medical Systems's competitors?

    Competitors of Aspect Medical Systems include Natus Medical, Ativa Medical, 20/20 GeneSystems, Infrascan, Third Eye Diagnostics and 12 more.

Compare Aspect Medical Systems to Competitors

E
Everest Biomedical

Everest currently markets a newborn hearing screening device that combines evoked otoacoustic emissions and auditory brainstem response. The company is based in St. Louis, MO, and has under development a hand-held, battery-operated monitoring device enabling the anesthetician to know what is happening in the entire brain while the patient is under anesthesia.

N
Neuro Diagnostic Devices

NeuroDx addresses important unmet needs in the neurosurgical market. Their lead product, ShuntCheck, is an aid to the detection offlow in implanted cerebrospinal fluid (CSF) shunts.

C
Cervimark

Cervimark is a medical diagnostics company that is developing a screening test for the prediction of pregnancies at high risk for preterm delivery. The test is based on quantifying biomarkers found in secretions of pregnant patients and correlating the resulting data to risk of pre-term labor. Proof of concept for this test has been demonstrated in a small human trial.

A
Ativa Medical

Ativa Medical is a medical diagnostics company that is working to make diagnostic test results available in moments, rather than hours and days.

M
MEC Dynamics

MEC Dynamics is a medical devices company developing and manufacturing point-of-care diagnostic products, using its proprietary technology. The company's devices have been designed for use in the both physician's office as well as the patient's home. They enable the 'real time' measurement of key blood analytes for early detection and more effective management of a variety of diseases including diabetes, cardiovascular diseases and cancer. Chronic and life-threatening diseases occurring in both industrial and developing countries could be better treated through early detection and proper monitoring. MEC aims to be a global developer and manufacturer of point-of-care diagnostic products using its technology platform. MEC's lead product, AvieA1c, is FDA 510K approved and NGSP certified.

T
Third Eye Diagnostics

Third Eye Diagnostics is developing the Cerepress, a first-of-its-kind non-invasive intracranial pressure monitor that gathers information from the patient's eye. The technology is based on one issued patent, one pending patent, and two applications in progress on methods and apparatus that correlate ICP with measurements taken from the blood vessels within the eye. The Cerepress measures blood pressure in the eye's central retinal vein (CRV) which highly correlates to intracranial pressure.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.